UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes

Experimental dermatology, 2010-08, Vol.19 (8), p.714-722

2010

Volltextzugriff (PDF)

IL-24 is expressed during wound repair and inhibits TGFα-induced migration and proliferation of keratinocytes

Experimental dermatology, 2010-08, Vol.19 (8), p.714-722

2010

Volltextzugriff (PDF)

Abstract 4527: The HER3-EREG axis and its role in colorectal cancer aggression

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4527-4527

2012

Volltextzugriff (PDF)

Abstract CC1-1-1: To clip or not to clip (Part 1)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.CC1-1-1-CC1-1-1

Caudle, Abigail

2023

Volltextzugriff (PDF)

Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT026-CT026

2022

Volltextzugriff (PDF)

Abstract GS4-05: Neoadjuvant chemotherapy (NCT) response in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) resistant to endocrine therapy (ET) in the ALTERNATE trial (Alliance A011106)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS4-05-GS4-05

2021

Volltextzugriff (PDF)

Abstract P5-14-17: Musculoskeletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS: CALGB 40903 (Alliance)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-14-17

2020

Volltextzugriff (PDF)

Abstract PD9-03: Pam50 intrinsic subtype and risk of recurrence score (ROR) for the prediction of endocrine (ET) sensitivity and pathologic response to chemotherapy in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) in the alternate trial (Alliance A011106)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD9-03-PD9-03

2022

Volltextzugriff (PDF)

Abstract PS1-17: Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS1-17-PS1-17

2021

Volltextzugriff (PDF)

Abstract PS9-13: Decision making process and contralateral prophylactic mastectomy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS9-13-PS9-13

2021

Volltextzugriff (PDF)

Acceptability of 3D‐printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study

Journal of surgical oncology, 2021-04, Vol.123 (5), p.1206-1214

2021

Volltextzugriff (PDF)

ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.504-504

2020

Volltextzugriff (PDF)

American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns

Annals of surgical oncology, 2012-10, Vol.19 (10), p.3144-3151

2012

Volltextzugriff (PDF)

Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer

Journal of surgical oncology, 2021-03, Vol.123 (4), p.846-853

2021

Volltextzugriff (PDF)

Applicability of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial results in invasive lobular carcinoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1103-1103

2013

Volltextzugriff (PDF)

ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy

Annals of surgical oncology, 2022-06, Vol.29 (6), p.3865-3866

2022

Volltextzugriff (PDF)

ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection

Annals of surgical oncology, 2024-08, Vol.31 (11), p.7271-7272

2024

Volltextzugriff (PDF)

ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.591-591

2021

Volltextzugriff (PDF)

Assessment for residual nodal disease after neoadjuvant chemotherapy with image-guided surgery

Journal of clinical oncology, 2014-09, Vol.32 (26_suppl), p.99-99

2014

Volltextzugriff (PDF)

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.1131-1141

2012

Volltextzugriff (PDF)

Biology, Treatment, and Outcome in Very Young and Older Women with DCIS

Annals of surgical oncology, 2012-11, Vol.19 (12), p.3777-3784

2012

Volltextzugriff (PDF)

Breast conservation therapy after neoadjuvant chemotherapy: Optimization of a multimodality approach

Journal of surgical oncology, 2014-07, Vol.110 (1), p.32-36

2014

Volltextzugriff (PDF)

Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience

Annals of surgery, 2020-08, Vol.272 (2), p.e106-e111

2020

Volltextzugriff (PDF)

Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)

Annals of surgical oncology, 2019-12, Vol.26 (13), p.4364-4371

2019

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes

IL-24 is expressed during wound repair and inhibits TGFα-induced migration and proliferation of keratinocytes

Abstract 4527: The HER3-EREG axis and its role in colorectal cancer aggression

Abstract CC1-1-1: To clip or not to clip (Part 1)

Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial

Abstract GS4-05: Neoadjuvant chemotherapy (NCT) response in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) resistant to endocrine therapy (ET) in the ALTERNATE trial (Alliance A011106)

Abstract P5-14-17: Musculoskeletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS: CALGB 40903 (Alliance)

Abstract PD2-10: Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): An ALTERNATE trial analysis (Alliance A011106)

Abstract PS1-17: Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery

Abstract PS9-13: Decision making process and contralateral prophylactic mastectomy

Acceptability of 3D‐printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study

ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106

American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns

Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer

Applicability of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial results in invasive lobular carcinoma

ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy

ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection

ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection

Assessment for residual nodal disease after neoadjuvant chemotherapy with image-guided surgery

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass

Biology, Treatment, and Outcome in Very Young and Older Women with DCIS

Breast conservation therapy after neoadjuvant chemotherapy: Optimization of a multimodality approach

Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience

Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)

Suchergebnisse filtern